The first in vivo High Throughput Screening platform for analgesics In order to support the early...
MRMT-1 TUMOR CELL-INDUCED BONE CANCER PAIN MODEL Bone is a privileged site of metastases for...
ANS Biotech announces a collaborative agreement with Oroxcell for the bioanalyses of sampled fluids & tissues !
ANS Biotech attended 17th World Congress on Pain in Boston, MA (September 12-16, 2018). ANS Biotech presented a poster titled: Comparison of the antinociceptive and antipruritic effects of kappa opioid receptor agonists on models of itch and pain.
ANS Biotech has a new publication intitled "Oral probiotic treatment of Lactobacillus rhamnosus Lcr35® prevents visceral hypersensitivity to a colonic inflammation and an acute psychological stress". J Applied Microbiol. 122, 188-200.